Alivus Life Sciences Limited (NSE:ALIVUS)
India · Delayed Price · Currency is INR 915.05
+5.05 (0.55%)
At close: Mar 6, 2026
Alivus Life Sciences Market Cap
Alivus Life Sciences has a market cap or net worth of 112.31 billion as of March 6, 2026. Its market cap has decreased by -10.67% in one year.
Market Cap
112.31B
Enterprise Value
106.39B
Revenue
25.12B
Ranking
n/a
PE Ratio
20.69
Stock Price
915.05
Market Cap Chart
Since August 6, 2021, Alivus Life Sciences's market cap has increased from 91.71B to 112.31B, an increase of 22.46%. That is a compound annual growth rate of 4.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 112.31B | -0.12% |
| Dec 31, 2025 | 112.45B | -6.68% |
| Dec 31, 2024 | 120.50B | 49.68% |
| Dec 29, 2023 | 80.51B | 56.38% |
| Dec 30, 2022 | 51.48B | -33.42% |
| Dec 31, 2021 | 77.32B | -15.69% |
| Aug 6, 2021 | 91.71B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gland Pharma | 274.98B |
| Emcure Pharmaceuticals | 268.42B |
| Wockhardt | 211.17B |
| Piramal Pharma | 201.66B |
| Eris Lifesciences | 188.49B |
| NATCO Pharma | 182.64B |
| Alembic Pharmaceuticals | 139.26B |
| Cohance Lifesciences | 107.08B |